RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK)
Market Cap | 796.57M |
Revenue (ttm) | 1.92B |
Net Income (ttm) | 37.68M |
Shares Out | 66.94M |
EPS (ttm) | 0.56 |
PE Ratio | 21.25 |
Forward PE | 17.76 |
Dividend | 0.10 (0.84%) |
Ex-Dividend Date | Jun 4, 2025 |
Volume | 3,439 |
Average Volume | 1,202 |
Open | 12.00 |
Previous Close | 11.90 |
Day's Range | 11.70 - 12.00 |
52-Week Range | 10.10 - 16.40 |
Beta | -0.03 |
RSI | 49.80 |
Earnings Date | Aug 7, 2025 |
About ETR:RHK
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. It also operates acute hospitals, medical care centers, and rehabilitation hospitals. The company was founded in 1973 and is based in Bad Neustadt an der Saale, Germany. [Read more]
Financial Performance
In 2024, ETR:RHK's revenue was 1.87 billion, an increase of 7.67% compared to the previous year's 1.73 billion. Earnings were 43.35 million, an increase of 11.98%.
Financial StatementsNews

Rhoen-Klinikum Shines in H1 2025 with Strong Performance
RHÖN-KLINIKUM AG showcases resilience with a 7.5% revenue rise, navigating challenges with a focus on digital transformation and strategic partnerships. Jetzt den vollständigen Artikel lesen

Rhoen-Klinikum Steady in Q1 2025, Confirms Positive Outlook
In Q1 2025, RHÖN-KLINIKUM AG treated over 240,000 patients, achieving an 8.3% revenue increase, despite economic challenges. Strategic partnerships and a focus on quality care position them for future...

Rhoen-Klinikum's Prof. Kaltenbach Exits After Stellar Year
RHÖN-KLINIKUM AG celebrates a thriving year, with revenues soaring and patient numbers climbing, as it sets ambitious targets for a sustainable future. Jetzt den vollständigen Artikel lesen

EQS-News: RHÖN-KLINIKUM AG once again reports a successful financial year – CEO Prof. Kaltenbach leaves the Board of Management as planned
EQS-News: RHÖN-KLINIKUM Aktiengesellschaft / Key word(s): Annual Report/Annual Results RHÖN-KLINIKUM AG once again reports a successful financial year – CEO Prof. Kaltenbach leaves the Board of Manage...

Rhoen-Klinikum Shines: Strong 9-Month Performance, Outlook Confirmed
RHÖN-KLINIKUM AG has shown robust growth in 2024, with significant increases in revenue, profit, and patient numbers, underscoring its position as a leading healthcare provider in Germany. Jetzt den v...

RHÖN-KLINIKUM AG: Strong H1 2024 Performance, Confident Outlook Ahead
RHÖN-KLINIKUM AG saw a robust first half of 2024, with revenues climbing 6.5% to 775.5 million euros and profits soaring 68.9% to 20.6 million euros, despite a tough market. Patient numbers and EBITDA...

EQS-News: First half of 2024: RHÖN-KLINIKUM AG continues good business performance – outlook confirmed
EQS-News: RHÖN-KLINIKUM Aktiengesellschaft / Key word(s): Half Year Results/Miscellaneous First half of 2024: RHÖN-KLINIKUM AG continues good business performance – outlook confirmed 08.08.2024 / 09:0...